dr. kimberly blackwell: treatment innovations in targeting the her-2 receptor - part 1
Published 13 years ago • 1.1K plays • Length 11:21Download video MP4
Download video MP3
Similar videos
-
6:07
dr. kimberly blackwell: treatment innovations in targeting the her-2 receptor - part 2
-
0:46
dr. kimberly l. blackwell on a promising her2 breast cancer treatment
-
1:04
dr. kimberly blackwell discusses the t-dm1 emilia trial coprimary endpoints
-
2:05
duke cancer institute's dr. kimberly blackwell discusses new treatment for breast cancer
-
2:18
kimberly blackwell, md: considerations for different therapi
-
5:06
safety outcomes in the phase iii monarche trial of abemaciclib et in hr , her2- breast cancer
-
2:58
what to know about skin cancer risks: healthlink
-
5:05
anti-her2 mechanisms of approved her2 inhibitors
-
1:50
dr. kimberly blackwell discusses the t-dm1 emilia trial
-
1:39
dr. blackwell on treatment landscape of her2 breast cancer
-
3:22
kimberly blackwell, md: expectations of therapy in breast cancer
-
3:05
duke cancer institute's dr. kim blackwell
-
2:13
kimberly blackwell, md: choices of therapy
-
4:36
kimberly blackwell on advances in the management of her2 patients.mp4
-
1:38
kimberly blackwell, md: considerations for different therapies in breast cancer
-
2:02
kimberly blackwell, md: expectations of therapy
-
7:11
clifford a. hudis, md: t-dm1 emilia trial for her-2 positive advanced breast cancer
-
2:20
duke pioneers gentler breast cancer drugs
-
4:30
kimberly blackwell on advances in the management of her2 patients
-
0:52
dr. blackwell on emerging therapies in tnbc